Hygiene Clinical Trial
Official title:
Study Title: Study for Dermatological Evaluation of Topic Compatibility Primary and Accumulated Dermical Irritability and Dermical Sensitivity for the Product Dermacyd PH_DESILSTY_FR (Lactic Acid) .
Verified date | September 2010 |
Source | Sanofi |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: National Health Surveillance Agency |
Study type | Interventional |
Primary Objective:
To demonstrate the absence of irritation potential (primary dermic irritability and
cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd
PHDESILSTYFR.
Status | Completed |
Enrollment | 55 |
Est. completion date | July 2009 |
Est. primary completion date | July 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion criteria: - Phototype Skin I,II, III e IV Integral skin test in the region - Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion; Exclusion criteria: - Lactation or gestation - Use of Antiinflammatory 30 days and/or immunossupression drugs for until 3 months before volunteers selection - Disease which can cause immunosuppresion, such as diabetes, HIV - Personnel history of atopy - History of sensitivity or irritation for topic products - Cutaneous active disease (local and/or general) which can modify the study results - Use of new drugs and/or cosmetics during the study - Cutaneous reactive - Previous participation in studies using the same product in test - Volunteer which has immunodeficiency congenital or acquired - Relevant history or confirmation of alcohol or other drugs abuse - Intolerance detected or suspected for some component of the sample tested - Medecin or sponsor employees or their close family. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial. |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Sanofi-Aventis Administrative Office | Sao Paulo |
Lead Sponsor | Collaborator |
---|---|
Sanofi |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the absence of primary and accumulated dermical irritability and dermical sensitivity by using International Contact Dermatitis Research Group (ICDRG) scale. | From the treatment start to the end of the study( treatment period 6 weeks) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02342860 -
The Impact of Improved WASH in Schools on Absence, Diarrhea and Helminth Infection in Lao PDR
|
N/A | |
Completed |
NCT00783939 -
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.
|
Phase 3 | |
Completed |
NCT00784121 -
Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility
|
Phase 3 | |
Completed |
NCT00783861 -
Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility
|
Phase 3 | |
Completed |
NCT00783640 -
Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation
|
Phase 3 | |
Completed |
NCT00784069 -
Dermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation
|
Phase 3 | |
Completed |
NCT00794612 -
Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.
|
Phase 3 | |
Completed |
NCT00793026 -
Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability
|
Phase 3 | |
Completed |
NCT04382690 -
Behavioral Determinants That May Influence People's Hand-hygiene and Environment Disinfecting
|
||
Completed |
NCT00761800 -
Dermacyd Teen Care Tangerina Mix - Compatibility
|
Phase 3 | |
Completed |
NCT00497783 -
Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)
|
Phase 4 | |
Completed |
NCT00497692 -
Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)
|
Phase 4 | |
Completed |
NCT00380991 -
Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene
|
Phase 3 | |
Completed |
NCT00371852 -
Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene
|
Phase 3 | |
Completed |
NCT03032887 -
Reducing Visitors- and Personnel-associated Infection Risk on Perinatal Care Station
|
N/A | |
Completed |
NCT00881270 -
Dermacyd Infantile - Acceptability.
|
Phase 4 | |
Completed |
NCT00679562 -
Lactacyd Radiance (Lactic Acid) Prophetic Patch Test
|
Phase 2 | |
Completed |
NCT00933075 -
Dermacyd Silver Frutal (Lactic Acid) - Photo Evaluation.
|
Phase 3 | |
Completed |
NCT00933842 -
Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on Floral
|
Phase 3 | |
Completed |
NCT00933504 -
Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral
|
Phase 3 |